Cargando…

Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care

AIMS: The aim of this study was to compare individuals with type 1 diabetes with continuous subcutaneous insulin infusion (CSII) and intensified insulin therapy (ICT) in routine care regarding metabolic control and treatment satisfaction. METHODS: Individuals with type 1 diabetes (CSII n = 74; ICT n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kramer, Guido, Kloos, Christof, Müller, Ulrich A., Wolf, Gunter, Kuniss, Nadine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305953/ https://www.ncbi.nlm.nih.gov/pubmed/34301317 http://dx.doi.org/10.1186/s13098-021-00700-0

Ejemplares similares

Successful Treatment with Bedtime Basal Insulin Added to Metformin without Weight Gain or Hypoglycaemia over Three Years
por: Mertes, Bernardo, et al.
Publicado: (2020)

Diabetes related distress is high in inpatients with diabetes
por: Kuniss, Nadine, et al.
Publicado: (2021)

Choosing an insulin injector by a structured, pharmaceutical-neutral curriculum via an informed shared decision-making process in 349 insulin-naive patients with diabetes mellitus
por: Mertes, Bernardo, et al.
Publicado: (2023)

Insulin Hypoglycæmia
Publicado: (1948)

A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
por: Heller, S., et al.
Publicado: (2015)

Practical application of short-term intensive insulin therapy based on the concept of “treat to target” to reduce hypoglycaemia in routine clinical site
por: Nakashima, Koji, et al.
Publicado: (2020)

Improvement of HbA(1c) and stable weight loss 2 years after an outpatient treatment and teaching program for patients with type 2 diabetes without insulin therapy based on urine glucose self-monitoring
por: Müller, Nicolle, et al.
Publicado: (2012)

Randomized Crossover Study to Examine the Necessity of an Injection-to-Meal Interval in Patients With Type 2 Diabetes and Human Insulin
por: Müller, Nicolle, et al.
Publicado: (2013)

Insulin‐based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study
por: Franc, S., et al.
Publicado: (2015)

Hypoglycaemia due to insulin therapy for the management of hyperkalaemia in hospitalised adults: A scoping review
por: Chothia, Mogamat-Yazied, et al.
Publicado: (2022)

The OmniPod Insulin Management System: the latest innovation in insulin pump therapy
por: Zisser, Howard C.
Publicado: (2010)

Use of fast‐acting insulin aspart in insulin pump therapy in clinical practice
por: Evans, Mark, et al.
Publicado: (2019)

Severe hypoglycaemia during intensive insulin therapy: a rare event in critically ill patients
por: Kaukonen, M, et al.
Publicado: (2007)

Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2
por: Hopf, Maximilian, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden
por: Jendle, Johan, et al.
Publicado: (2017)

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands
por: Roze, Stephané, et al.
Publicado: (2019)

Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used
por: Norwood, Paul, et al.
Publicado: (2017)

Insulin pump therapy in transient neonatal diabetes mellitus
por: Park, Joong Heum, et al.
Publicado: (2013)

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin
por: Khunti, K., et al.
Publicado: (2016)

Performance of a predictive algorithm in sensor-augmented pump therapy in the prevention of hypoglycaemia
por: Abraham, Mary, et al.
Publicado: (2015)

Glucose control and the incidence of severe hypoglycaemia in a burns population following the introduction of intensive insulin therapy
por: Arawwawala, D, et al.
Publicado: (2008)

Approach to assessing the economic impact of insulin‐related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool
por: Parekh, W. A., et al.
Publicado: (2015)

Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia
por: Reviriego, J, et al.
Publicado: (2008)

First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy
por: Waldenmaier, Delia, et al.
Publicado: (2018)

Glucose/insulin-glargine/insulin-lispro: Hepatic glycogenosis, hypoglycaemia and acute hepatitis: case report
Publicado: (2021)

Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus
por: Tołwińska, Joanna, et al.
Publicado: (2013)

Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
por: Boucher-Berry, Claudia, et al.
Publicado: (2016)

Insulin Pump Therapy Training and Management: An Opportunity for Community Pharmacists
por: Boyd, LeAnn C., et al.
Publicado: (2008)

Abstract 17: Spontaneous hypoglycaemia due to insulin autoimmune syndrome in five cases, response to steroid therapy and rituximab
por: Batra, C M, et al.
Publicado: (2022)

Hypoglycaemia is reduced with use of inhaled Technosphere(®) Insulin relative to insulin aspart in type 1 diabetes mellitus
por: Seaquist, E. R., et al.
Publicado: (2019)

Severe hypoglycaemia in adults with insulin‐treated diabetes: impact on healthcare resources
por: Heller, S. R., et al.
Publicado: (2015)

Insulin Autoimmune Syndrome: a rare case of hypoglycaemia resolving with immunosuppression.
por: Hunter, A, et al.
Publicado: (2018)

Reporting of hypoglycaemia in clinical trials of basal insulins: A need for consensus
por: Frier, Brian M., et al.
Publicado: (2019)

Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
por: Ly, Trang T., et al.
Publicado: (2018)

Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire)
por: Messina, Rossella, et al.
Publicado: (2023)

The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy
por: Zhang, Xing-Guang, et al.
Publicado: (2018)

GlucoTab‐guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes
por: Aberer, Felix, et al.
Publicado: (2018)

Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia: Reduction in nocturnal hypoglycemia in those at greatest risk
por: Choudhary, Pratik, et al.
Publicado: (2011)

Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
por: Regittnig, Werner, et al.
Publicado: (2021)

Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes
por: Rodbard, H W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8v6nfsuda8ink18mig30415sfp